الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
31 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
32 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
34 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
35 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Matta Gerges Mounir Meshreky 2021
36 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
37 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Mubarak Hefni Ismail 2021
38 Validation of imaging reporting and data system of coronavirus disease 2019 lexicons CO-RADS and COVID-RADS with radiologists’ preference: a multicentric study Dr. Adel Gomaa Mohamed Gabr 2021
39 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Hanaan Ahmed Mohammed Ahmed 2021
40 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Hossam El-Din / Mostafa Kamel Mohamed 2021